Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and laboratory services, announced today that it has received a Notice of Allowance ...

GloboCare has received a Notice of Allowance from the China National Intellectual Property Administration for its patent ...

Creating cancer therapies based around natural killer cells could offer similar levels of efficacy to CAR-T therapies, but at around one hundredth of the cost. Researchers at MD Anderson Cancer ...

and efficacy of CAR-T and CAR-Natural Killer (NK) cells. Its key features include: Bispecific Anti-CD19xCD22 CAR: This design targets both CD19 and CD22 antigens, minimizing the risk of tumor ...

NK cells are emerging as a potentially safer and more convenient alternative to the current generation of CAR-T cell therapies – which include Gilead/Kite's Yescarta (axicabtagene ciloleucel ...

A cancer therapy that uses genetically engineered immune cells, called CAR T-cells, has kept a person free of a potentially fatal nerve tumour for a record-breaking 18 years. “This is ...

Auto insurance is a safeguard and can lessen the financial burden of a car accident, but only if you have the proper coverage. The best car insurance will offer solid coverage without going ...

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging ...

Toyota last week unveiled its third-generation hydrogen fuel-cell stack, demonstrating continued ... On the passenger-car side, it's clear Toyota is putting effort into the product.

President Donald Trump threatened to place a tariff of around 25% on cars imported into the United States, a policy that could raise prices on cars from most automakers – including American car ...